Regulation of type II collagen expression by cyclin-dependent kinase 6, cyclin D1, and p21 in articular chondrocytes

IUBMB Life

Volumn 59, Issue 2, 2007, Pages 90-98

  Hwang, Sang Gu ^a   Song, Sung Min ^a   Kim, Jeong Ran ^a   Park, Chun Shik ^a   Song, Woo Keun ^a   Chun, Jang Soo ^a  

^a Gwangju Institute of Science and Technology (GIST)   (South Korea)

Author keywords

Chondrocytes; Cyclin D1; Cyclin dependent kinase kinase 6; p21; Type II collagen

Indexed keywords

COLLAGEN TYPE 2; CYCLIN D1; CYCLIN DEPENDENT KINASE 6; CYCLIN DEPENDENT KINASE INHIBITOR; INTERLEUKIN 1BETA; P21 ACTIVATED KINASE;

ANIMAL CELL; ARTICLE; CARTILAGE CELL; CONTROLLED STUDY; DOWN REGULATION; ENZYME ACTIVITY; ENZYME REGULATION; NONHUMAN; PROTEIN EXPRESSION; UPREGULATION;

ANIMALS; BLOTTING, WESTERN; CHONDROCYTES; COLLAGEN TYPE II; CYCLIN D1; CYCLIN-DEPENDENT KINASE 2; CYCLIN-DEPENDENT KINASE 6; CYCLIN-DEPENDENT KINASE INHIBITOR P21; GENE EXPRESSION REGULATION; INTERLEUKIN-1BETA; JNK MITOGEN-ACTIVATED PROTEIN KINASES; RABBITS;

EID: 34047237535     PISSN: 15216543     EISSN: 15216551     Source Type: Journal    
DOI: 10.1080/15216540701245022     Document Type: Article

References (29)

1. DeLise, A. M., Fischer, L., and Tuan, R. S. (2000) Cellular interactions and signaling in cartilage development. Osteoarthr. Cart. 8, 309-334.
2. Fukui, N., Purple, C. R., and Sandell, L. J. (2001) Cell biology of osteoarthritis: the chondrocyte's response to injury. Curr. Rheumatol. Rep. 3, 496-505.
3. Ng, L. J., Wheatley, S., Muscat, G. E., Conway-Campbell, J., Bowles, J., Wright, E., Bell, D. M., Tam, P. P., Cheah, K. S., and Koopman, P. (1997) SOX9 binds DNA, activates transcription, and coexpresses with type II collagen during chondrogenesis in the mouse. Dev. Biol. 183, 108-121.
4. Lefebvre, V., Huang, W., Harley, V. R., Goodfellow, P. N., and de Crombrugghe, B. (1997) SOX9 is a potent activator of the chondrocyte-specific enhancer of the pro alpha 1 (II) collagen gene. Mol. Cell. Biol. 17, 2336-2346.
5. Sandell, L. J., and Aigner, T. (2001) Articular cartilage and changes in arthritis. An introduction: cell biology of osteoarthritis. Arthr. Res. 3, 107-113.
6. Martel-Pelletier, J., Alaaeddine, N., and Pelletier, J. P. (1999) Cytokines and their role in the pathophysiology of osteoarthritis. Front. Biosci. 4, 694-703.
7. Huh, Y. H., Kim, S. H., Kim, S. J., and Chun, J. S. (2003) Differentiation status-dependent regulation of cyclooxygenase-2 expression and prostaglandin E2 production by epidermal growth factor via mitogen-activated protein kinase in articular chondrocytes. J. Biol. Chem. 278, 9691-9697.
8. Amin, A. R., and Abramson, S. B. (1998) The role of nitric oxide in articular cartilage breakdown in osteoarthritis. Curr. Opin. Rheumatol. 10, 263-268.
9. Kim, S. J., Ju, J. W., Oh, C. D., Yoon, Y. M., Song, W. K., Kim, J. H., Yoo, Y. J., Bang, O. S., Kang, S. S., and Chun, J. S. (2002) ERK-1/2 and p38 kinase oppositely regulate nitric oxide-induced apoptosis of chondrocytes in association with p53, caspase-3, and differentiation status. J. Biol. Chem. 277, 1332-1339.
10. Kim, S. J., Kim, H. G., Oh, C. D., Hwang, S. G., Song, W. K., Yoo, Y. J., Kang, S. S., and Chun, J. S. (2002) p38 kinase-dependent and -independent inhibition of protein kinase C zeta and -alpha regulates nitric oxide-induced apoptosis and dedifferentiation of articular chondrocytes. J. Biol. Chem. 277, 30375-30381.
11. Yoon, Y. M., Kim, S. J., Oh, C. D., Ju, J. W., Song, W. K., Yoo, Y. J., Huh, T. L., and Chun, J. S. (2002) Maintenance of differentiated phenotype of articular chondrocytes by protein kinase C and extracellular signal-regulated protein kinase. J. Biol. Chem. 277, 8412-8420.
12. Ryu, J. H., Kim, S. J., Kim, S. H., Oh, C. D., Hwang, S. G., Chun, C. H., Oh, S. H., Seong, J. K., Huh, T. L., and Chun, J. S. (2002) Regulation of the chondrocyte phenotype by beta-catenin. Development 129, 5541-5550.
13. Hwang, S. G., Ryu, J. H., Kim, I. C., Jho, E. H., Jung, H. C., Kim, K., Kim, S. J., and Chun, J. S. (2004) Wnt-7a causes loss of differentiated phenotype and inhibits apoptosis of articular chondrocytes via different mechanisms. J. Biol. Chem. 279, 26597-26604.
14. Hwang, S. G., Yu, S. S., Poo, H., and Chun, J. S. (2005) c-Jun/activator protein-1 mediates interleukin-1betainduced dedifferentiation but not cyclooxygenase-2 expression in articular chondrocytes. J. Biol. Chem. 280, 29780-29787.
15. Hwang, S. G., Yu, S. S., Lee, S. W., and Chun, J. S. (2005) Wnt-3a regulates chondrocyte differentiation via c-Jun/AP-1 pathway. FEBS Lett. 579, 4837-4842.
16. Beier, F., Leask, T. A., Haque, S., Chow, C., Taylor, A. C., Lee, R. J., Pestell, R. G., Ballock, R. T., and Luvalle, P. (1999) Cell cycle genes in chondrocyte proliferation and differentiation. Matrix Biol. 18, 109-120.
17. Beier, F. (2005) Cell-cycle control and the cartilage growth plate. J. Cell. Physiol. 202, 1-8.
18. Luvalle, P., and Beier, F. (2000) Cell cycle control in growth plate chondrocytes. Front. Biosci. 5, 493-503.
19. Morgan, D. O. Cyclin-dependent kinases: engines, clocks, and microprocessors. Annu. Rev. Cell Dev. Biol. 13, 261-291.
20. Waldman, T., Kinzler, K. W., and Vogelstein, B. (1995) p21 is necessary for the p53-mediated G1 arrest in human cancer cells. Cancer Res. 55, 5187-5190.
21. Lu, H., Chang, D. J., Baratte, B.,Meijer, L., and Schulze-Gahmen, U. (2005) Crystal structure of a human cyclin-dependent kinase 6 complex with a flavonol inhibitor, fisetin. J. Med. Chem. 48, 737-743.
22. Negishi, Y., Ui, N., Nakajima, M., Kawashima, K., Maruyama, K., Takizawa, T., and Endo, H. (2001) p21Cip-1/SDI-1/WAF-1 gene is involved in chondrogenic differentiation of ATDC5 cells in vitro. J. Biol. Chem. 276, 33249-33256.
23. Moro, T., Ogasawara, T., Chikuda, H., Ikeda, T., Ogata, N., Maruyama, Z., Komori, T., Hoshi, K., Chung, U. I., Nakamura, K., Okayama, H., and Kawaguchi, H. (2005) Inhibition of Cdk6 expression through p38 MAP kinase is involved in differentiation of mouse prechondrocyte ATDC5. J. Cell. Physiol. 204, 927-933.
24. Aikawa, T., Segre, G. V., and Lee, K. (2001) Fibroblast growth factor inhibits chondrocytic growth through induction of p21 and subsequent inactivation of cyclin E-Cdk2. J. Biol. Chem. 276, 29347-29352.
25. Ballock, R. T., Zhou, X., Mink, L. M., Chen, D. H., Mita, B. C., and Stewart, M. C. (2000) Expression of cyclin dependent kinase inhibitors in epiphyseal chondrocytes induced to terminally differentiate with thyroid hormone. Endocrinology 141, 4552-4557.
26. Lim, J. T., Mansukhani, M., and Weinstein, I. B. (2005) Cyclin-dependent kinase 6 associates with the androgen receptor and enhances its transcriptional activity in prostate cancer cells. Proc. Natl. Acad. Sci. USA 102, 5156-5161.
27. Sarruf, D. A., Iankova, I., Abella, A., Assou, S., Miard, S., and Fajas, L. (2005) Cyclin D3 promotes adipogenesis through activation of peroxisome proliferator-activated receptor gamma. Mol. Cell. Biol. 25, 9985-9995.
28. Stewart, M., Farnum, C., and MacLeod, J. (1997) Expression of p21CIP1/WAF1 in chondrocytes. Calcif. Tissue Int. 61, 199-204.
29. Ogasawara, T., Kawaguchi, H., Jinno, S., Hoshi, K., Itaka, K., Takato, T., Nakamura, K., and Okayama, H. (2004) Bone morphogenetic protein 2-induced osteoblast differentiation requires Smad-mediated down-regulation of Cdk6. Mol. Cell. Biol. 24, 6560-6568.